Skip to main content
. 2020 Nov 20;11:581543. doi: 10.3389/fmicb.2020.581543

TABLE 1.

Lists of papers referenced.

Country Sequence type(s) Capsule type(s) Resistance mechanism(s) Plasmid replicon type(s) Formation mechanisms* References
China ST29 (n = 1) K54 (n = 1) blaNDM–5 (n = 1) pvirIncHI1/IncFIB presIncX3 ∘∘ Yuan et al., 2019
ST1764 (n = 7) ST11 (n = 6) K64 (n = 7) K47 (n = 4), K64 (n = 2) blaNDM–1 (n = 7) blaKPC–2 (n = 6) NA NA Liu Z. et al., 2019
ST86 (n = 1) K2 (n = 1) blaNDM–1, blaKPC–2 co-carrying (n = 1) pvirIncHI1/IncFIB presIncFII(K) and presIncN ∘∘ Liu Y. et al., 2019
ST11 (n = 12) ST23 (n = 1) ST660 (n = 1) ST1660 (n = 1) K64 (n = 7), K47 (n = 5) K1 (n = 1) K16 (n = 1) K1 (n = 1) blaKPC–2 (n = 15) NA NA Xu et al., 2019
ST65 (n = 1) K2 (n = 1) blaCTX–M–3, blaCTX–M–14 coharboring NA NA Fu et al., 2019
ST23 (n = 1) K1 (n = 1) blaVIM–1 (n = 1) pvirIncHI1B/IncFIBk presIncA and presIncFII ∘∘ Dong et al., 2019
ST23 (n = 1) K1 (n = 1) blaNDM–1 (n = 1) NA ∘∘ Liu and Su, 2019
ST25 (n = 16) ST11 (n = 3) ST375 (n = 1) K2 (n = 16) Non-typeable (n = 3) K2 (n = 1) blaKPC–2 (n = 10), blaNDM–1 (n = 1), ESBLS (n = 5) blaKPC–2 (n = 3) ESBLS (n = 1) NA NA Li et al., 2019
ST15 (n = 7) KL112 (n = 7) blaOXA–232 (n = 7) presOXAColKP3-type presCTX IncFII presMDRIncFIB pvirIncHI1B/IncFIB ∘∘ Shu et al., 2019
ST23 (n = 1) K1 (n = 1) blaCTX–M–24 (n = 1) pvirCTXM IncHI1B/IncFIB Shen et al., 2019
ST23 (n = 2) ST412 (n = 1) ST660 (n = 1) ST700 (n = 1) K1 (n = 2) K57 (n = 1) K16 (n = 1) K1 (n = 1) Undefined (n = 2) PhoQD150G (n = 1) PhoQD150G (n = 1) mcr-1 and PhoQD150G (n = 1) NA NA Lu et al., 2018
ST23 (n = 1) K1 (n = 1) blaDHA–1 (n = 1) presDHAIncHI5 pvirIncHI1B/IncFIB ∘∘ Xie et al., 2018
ST2922 (n = 1) K1 (n = 1) blaDHA and blaCTX–M–14 (n = 1) presIncR pvirIncFIB/IncHI1B NA Xu et al., 2018
ST36 (n = 1) K62 (n = 1) blaKPC–2 (n = 1) pressKPC IncFII pvir IncHI1/IncFIB ∘∘ Feng et al., 2018
ST11 (n = 1) K47 (n = 1) blaKPC–2 (n = 1) pressKPCIncR,IncFII, IncNpresMDR IncA/C2 pvir IncHI1B/IncFIB ∘∘ Huang et al., 2018
Unknown (n = 18) K1 (n = 18) ESBLS and overexpression of efflux pumps (n = 18) NA NA Lin et al., 2018
ST86 (n = 1) K2 (n = 1) blaNDM–1- and blaKPC–2- Coproducing (n = 1) NA NA Wei et al., 2018
ST11 (n = 3) Unknown (n = 3) blaKPC–2 or blaNDM–1 (n = 3) NA NA Wong et al., 2018
ST11 (n = 1) Unknown (n = 1) tet(A) variant and blaKPC–2 (n = 1) NA Gu et al., 2018
ST11 (n = 3) K47 (n = 3) blaKPC–2 (n = 3) NA ∘∘ Gu et al., 2017 Dong et al., 2018b
ST11 (n = 4) Unknown (n = 4) tet(A) variant and blaKPC–2 (n = 1) NA ∘∘ Yao et al., 2018
ST11 (n = 16) ST268 (n = 2) ST65 (n = 1) ST692 (n = 1) ST595 (n = 1) K20(n = 5),non-T(n = 11) K20(n = 1),non-T(n = 1)K2 (n = 1) non-T (n = 1) non-T (n = 1) blaKPC–2 and blaSHV-11 (n = 16) blaKPC–2 and blaSHV-11 (n = 2) blaKPC–2 and blaSHV-11 (n = 1) blaKPC–2 and blaSHV-11 (n = 1) blaKPC–2 (n = 1) NA NA Zhan et al., 2017
ST23 (n = 2) ST268 (n = 3) ST65 (n = 1) ST17 (n = 1) ST420 (n = 1) ST367 (n = 1) ST1658 (n = 1) ST35 (n = 1) K1 (n = 2) K1 (n = 1),K20 (n = 2) K2 (n = 1) Non-typeable (n = 1) K20 (n = 1) K1 (n = 1) K2 (n = 1) Non-typeable (n = 1) SHV-75, CTXM-55, SHV-11, TEM-1, CTX-M-like, SHV-148, CTX-M-14, TEM-53 (n = 11) NA NA Zhang Y.W. et al., 2016
ST86 (n = 7) ST37 (n = 6) ST23 (n = 5) Unknown ESBLS (n = 18) NA NA Zhang J. et al., 2016
ST661 (n = 1) K1 (n = 1) mcr-1 (n = 1) NA NA Gu et al., 2016
ST14 (n = 1) K2 (n = 1) blaNDM–5 (n = 1) NA NA Liu et al., 2016
ST11 (n = 1) K1 (n = 1) blaKPC–2 (n = 1) pvirsKPCIncFIIk Wei et al., 2016
ST23 (n = 1)
ST23 (n = 1)
ST1797 (n = 3)
K1 (n = 1)
K1 (n = 1)
K1 (n = 3)
blaKPC–2 (n = 1)
blaKPC–2 (n = 1)
blaKPC–2 (n = 3)
pvirsKPCIncHI1B/IncFIB
NA
NA

∘∘
Zhang R. et al., 2015 Dong et al., 2018a
ST65 (n = 1) K2 (n = 1) SHV-11,TEM-53-producing ompK35,36 decreased (n = 1) NA NA Zhang Y.W. et al., 2015
ST25 (n = 2) ST65 (n = 5) ST11 (n = 1) K2 (n = 2) K2 (n = 5) Non-typeable (n = 1) blaKPC–2 (n = 6) NA NA Yao et al., 2015
Unknown (n = 5) K1 and K2 (n = 5) ESBLS (n = 5) NA NA Li et al., 2014
United Kingdom ST101 (n = 3) ST383 (n = 3) ST147 (n = 4) ST15 (n = 2) ST48 (n = 1) Unknown blaOXA-48 and MDR (n = 1), MDR (n = 2) blaOXA-48 (n = 1), blaNDM–5 (n = 2), MDR (n = 1) blaNDM–1 and MDR (n = 2), MDR (n = 2) blaNDM and MDR (n = 1), MDR (n = 1) blaNDM–5 and MDR (n = 1) pvirMDROXA–48 and (or) -NDM IncFII(K)/IncFIB(K) presOXA–48IncL/M presNDM–1IncFIB(pQil) pvirNDM–5 IncFIB(Mar) Turton et al., 2017, 2019
Argentina ST25 (n = 1) K2 (n = 1) blaKPC–2 (n = 1) NA NA Cejas et al., 2019
Japan ST23 (n = 1) K1 (n = 1) blaIMP-6 (n = 1)qq presIMP–6IncN ∘∘ Harada et al., 2019
Norway ST15 (n = 2) K24 (n = 2) ESBLS (n = 2) pvirCTXM IncFIBK_1/IncFIIK_1 Lam et al., 2019
Iran ST23 (n = 5) K1 (n = 5) blaVIM-2 (n = 5) presVIM–2IncN ∘∘ Tabrizi et al., 2018
United Kingdom ST23 (n = 1) K1 (n = 1) blaNDM–1 (n = 1) NA NA Roulston et al., 2018
Italy ST512 (n = 1) Unknown (n = 1) blaKPC-3 (n = 1) NA NA Arena et al., 2017
France ST86 (n = 1) K2 (n = 1) blaCTX–M–3 (n = 1) presIncL/M NA Surgers et al., 2016
India ST2318 (n = 1) Non-typeable (n = 1) ESBLS (n = 1) NA NA Shankar et al., 2016b
India ST11 (n = 1) ST43 (n = 1) ST231 (n = 1) Unknown blaOXA–232, blaOXA–181, blaOXA–1, blaNDM–1 IncFIA IncFIB IncFII IncHI1B Col NA Shankar et al., 2016a
India ST14 (n = 1) Unknown (n = 1) Mutation in OmpK36 (n = 1) NA NA Rafiq et al., 2016
United States ST23 (n = 1) Unknown (n = 1) blaKPC–2 (n = 1) presKPCIncFIA NA Cejas et al., 2014
Brazil ST11 (n = 7) Unknown (n = 7) blaKPC–2 qnrS1 blaCTX-M-2 (n = 7) pressKPCIncFIIk NA Andrade et al., 2014

*Single ∘ represents acquiring hybrid plasmid by KPs, double ∘∘ represents acquiring additional plasmid(s), pvir by MDR KPs or pres by hvKPs, respectively.